(Q46891007)

26 December 2017

title

A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase (English)

1 reference

26 December 2017

1 reference

Banerjee T

1

1 reference

26 December 2017

Duhadaway JB

2

1 reference

26 December 2017

Gaspari P

3

1 reference

26 December 2017

Sutanto-Ward E

4

1 reference

26 December 2017

Munn DH

5

1 reference

26 December 2017

Mellor AL

6

1 reference

26 December 2017

Malachowski WP

7

1 reference

26 December 2017

Prendergast GC

8

1 reference

26 December 2017

Muller AJ

9

1 reference

26 December 2017

language of work or name

English

0 references

publication date

19 November 2007

1 reference

26 December 2017

published in

Oncogene

1 reference

26 December 2017

volume

27

1 reference

26 December 2017

issue

20

1 reference

26 December 2017

page(s)

2851-2857

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210939

exact match

0 references

cites work

Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

The comparative pathology of human and mouse mammary glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

Isobrassinin and its analogues: novel types of antiproliferative agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

Cyclodextrin-based pharmaceutics: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

CTLA-4-Ig regulates tryptophan catabolism in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

IDO expression by dendritic cells: tolerance and tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

Prevention of allogeneic fetal rejection by tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

Cruciferous vegetables and cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

Botanicals in cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

Cruciferous phytoalexins: antiproliferative effects in T-Jurkat leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

New colorimetric cytotoxicity assay for anticancer-drug screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

inferred from DOI database lookup

7 January 2021

based on heuristic

Novel Sulfur-Containing Phytoalexins from the Chinese CabbageBrassica campestrisL. ssp.pekinensis(Cruciferae)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

inferred from DOI database lookup

7 January 2021

based on heuristic

Isolation of three novel sulphur-containing phytoalexins from the chinese cabbage Brassica campestris L. ssp. pekinensis(cruciferae)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210939

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1210939

1 reference

26 December 2017

PubMed ID

18026137

1 reference

26 December 2017